Skip to content

CARLIXE

Active Private limited companyfounded 2010active for 16 yearsWalakker 30, 8200 BrugesKBO/BCE: BE 0825.891.553

Lifetime

15 annual accounts with figures on one time axis
peak of €1.4m in 2024
€154▼ 100.0%
lowest -€20,054 in 2011
-€525▼ €964,150
peak of €1.8m in 2024
€1.7m▼ 6.2%
€114,357▼ 23.6%
peak of 0.3 FTE in 2015
-not published
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
19-01-202612 days before the deadline
2025micro format
Gross margin from €1.4m to €154Loss of €525Dividend €114,188Debts from €149,612 to €114,357Cash from €969,370 to €19,578

Key points

from the 2025 annual accounts

Equity

€1.7m ▼ 6.2%
1.82024-0.00Loss-0.1Dividend1.72025

CARLIXE paid out €114,188 in dividends in a year with a loss of €525.

Result

-€525 -€525
€964,0002024-€5252025

From profit to loss in 2025, after a profit of €963,625 in 2024.

Turnover

≈ €950 estimated

The micro format states no turnover.

Liquidity

67.28 was 47.81 in 2024

Short-term debts fell from €36,857 to €24,445.

Filings

15 annual accounts since 2011
deadline201520202025

The last five annual accounts were filed 4 to 28 days before the end of the period.

Position in the sector

-€525

Lower net result than 91% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,689 companies had the same profile as CARLIXE has now. Each dot stands for 7 companies, two years later.

93.6%
were still trading
5.5%
stopped another way
0.6%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,689 companies, not a prediction for CARLIXE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0825891553
Company renamed from Dr. to CARLIXE changes role from manager to director · “Het verlenen van advies en management alsook het uitvoeren van alle studies en onderzoek, het verrichten van…” (deed in Dutch) · General meeting of 30-11-2023 · Gazette deed
Registered office moved from Leuven to Sint-Michiels The registered office moved from Kortrijksestraat 191, 3010 Leuven (Kessel-Lo) to Walakker 30, bus 1, 8200 Sint-Michiels (Brugge) · Gazette deed
Incorporation Founded by · Founding capital of €18,600, 186 shares, €12,400 paid up · appointed as manager · published on 26-05-2010 · Gazette deed
All 30 events

Comparable companies

same main activity, similar in size and age
Company
CARLIXE Bruges €1.8m €154 93.8% -
Dokters Elst Philippe & Meels Danielle Schilde €1.6m -€14,773 35.1% -
DOKTER ERIK HENDRICKX Tongeren-Borgloon €1.5m -€5,994 98.9% -
Visiontrade Merchtem €2.4m -€103,121 98.8% -
DR. MARC FOL Londerzeel €2.3m -€84,821 99.9% -
DR. NELE DE RUYTER Ghent €1.1m -€33,493 14.5% -
DR. ROELANDT W. Ostend €2.2m -€12,235 97.3% -

These companies have the same main activity as CARLIXE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.1m and €2.4m, founded between 1999 and 2010.

Official details

Source: KBO
Status
Active since 07-05-2010Normal situation
Activity
Specialist medical practiceNACE 86220
Joint committee
330Health institutions and services · annual accounts 30-06-2023
Establishment unit
2.190.923.0633010 Leuven, since 07-05-2010
Financial year end
30 June
Peppol
Reachable since 05-03-2025
Company details

Annual accounts to 30-06-2025

€1.8m▼ 7.5%
Filing
Filed on 19-01-2026, 12 days before the end of the filing period
Financials

Insights on CARLIXE

CARLIXE files the micro format. That format states no turnover. The gross margin fell from €29,368 in 2011 to €154 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CARLIXE

What is the company number of CARLIXE?
The company number of CARLIXE is 0825.891.553. The VAT number is the same number with BE in front: BE 0825.891.553.
Where is CARLIXE based?
The registered office is at Walakker 30, 8200 Bruges.Company details
What does CARLIXE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of CARLIXE?
CARLIXE is a private limited company (BV).
When was CARLIXE founded?
CARLIXE was founded on 07-05-2010.
Is CARLIXE still active?
Yes, CARLIXE is an active enterprise in the KBO register.
How many employees does CARLIXE have?
CARLIXE had an average of 0.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does CARLIXE fall under?
In its 30-06-2023 annual accounts, CARLIXE states joint committee 330 (Health institutions and services).
What is the turnover of CARLIXE?
The turnover in financial year 2025 is about €950. This figure is estimated from the gross margin of €154 and 52 comparable companies (NACE 86). It probably lies between €660 and €1,700. It is a rough estimate.
Is CARLIXE profitable?
In financial year 2025, CARLIXE made a loss of €525.
Where can I find the annual accounts of CARLIXE?
CARLIXE filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CARLIXE due?
CARLIXE must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.